SynthesisFrontiers in immunology2021

Comparison of Efficacy and Safety of Single and Double Immune Checkpoint Inhibitor-Based First-Line Treatments for Advanced Driver-Gene Wild-Type Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis.

Qian Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.